ArticleCureus2025
Vitamin B6 Deficiency May Not Always Present As Microcytic Hypochromic Anemia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective Vitamin B6 (VB6) deficiency leads to microcytic hypochromic anemia with ringed sideroblasts. Sideroblastic anemia due to VB6 deficiency is an important differential diagnosis to consider in cases with sideroblastic anemia associated with myelodysplastic syndrome (MDS). However, VB6 screening is underutilized in Japan as it is not covered by the national health insurance system, potentially leading to low screening rates. Methods This study retrospectively evaluated the relationships between VB6 (pyridoxal (PAL)) and other clinical parameters, including anemia, with univariate and multivariate regression analysis. Among 43 patients, we excluded one case where vitamin B6 supplementation had already started before blood sampling. We enrolled 42 patients who had undergone measurement of VB6 level (PAL) at Toho University Sakura Medical Center (Sakura, JPN) between September 2010 and October 2023. Results The PAL levels were significantly correlated with mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH). Mean corpuscular hemoglobin concentration (MCHC) and vitamin B12 (VB12) also tended to correlate positively with PAL; however, no correlation was observed between PAL levels and other parameters. The PAL was positively correlated only with MCV and MCH in the subgroup analysis of hematological disorders alone. Only alkaline phosphatase (ALP) showed a significant decrease in the PAL <6 ng/mL group compared with the PAL ≥6 ng/mL groups; no significant differences were observed in RBCs, hemoglobin (Hgb), MCV, MCH, or MCHC between the PAL <6 and ≥6 ng/mL groups in both the overall cohort of 42 patients and the subset of 12 patients with hematological disease. Multivariate regression analysis revealed that only RBC and MCV levels independently and significantly affected Hgb levels. Conclusions These findings suggest that anemia due to VB6 deficiency may not always present as microcytic hypochromic anemia. Thus, VB6 deficiency must be included in the differential diagnosis of anemia, especially when there's suspicion for MDS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.